DOCS · Doximity Inc.
The AI's read
Doximity reported Q1 revenue of $156.6M, beat estimates, raised its full-year sales outlook, and the CEO said AI is unlocking a bigger commercial market. The stock ripped higher and a short squeeze amplified the move, with over 16% of float sold short. Market reaction is huge, up ~32.7% today, so a lot is already priced into the headline narrative. Still, the company showed measurable AI traction: 165 health systems using AI, workflow prescriber growth >30%, and sequential AI Search queries +25%. We lean bullish because the beat, upgraded outlook, and clear product adoption point to real upside beyond a one-day pop. Conviction is tempered by the size of the rally and short-squeeze noise, so treat this as opportunity with execution risk and watch follow-up prints.